港股通创新药ETF工银获融资买入1.24亿元，近三日累计买入2.16亿元

Core Viewpoint - The article discusses the recent trading activity of the Hong Kong Stock Connect Innovative Drug ETF, highlighting significant financing buy-ins and net selling figures over a three-day period [1]. Group 1: Financing Activity - On August 6, the Hong Kong Stock Connect Innovative Drug ETF received a financing buy-in of 124 million yuan, ranking 318th in the two markets [1]. - Over the last three trading days (August 4-6), the ETF saw financing buy-ins of 26 million yuan, 66 million yuan, and 124 million yuan respectively [1]. - The financing repayment amount on August 6 was 131 million yuan, resulting in a net sell of approximately 779,970 yuan [1]. Group 2: Short Selling Activity - On August 6, there were no shares sold short, resulting in a net short sale of 0 shares [1].